Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion type Assertion NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_head.
- NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion description "[To evaluate whether DLC-1 could be a therapeutic target for non-Hodgkin lymphoma (NHL), we examined the expressions of DLC-1 in Burkitt's lymphoma (BL) cell lines and tested the effects of DLC-1 on cellular growth and migration in BL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_provenance.
- NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion evidence source_evidence_literature NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_provenance.
- NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion SIO_000772 20882354 NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_provenance.
- NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion wasDerivedFrom befree-20150227 NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_provenance.
- NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_assertion wasGeneratedBy ECO_0000203 NP832781.RAXylJ13UGQfrj8-W-v1PWr2Ay_kh_enBQAxuCFLe0iAs130_provenance.